Trends in Manufacturing eBook
Read the article:
Implementing Continuous Bioprocessing: From Theory to Practice
Read the eBook:
Pharmaceutical Technology’s Trends in Manufacturing eBook
The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.
The evolution of technologies on the bioprocessing front is enabling an ability to perform continuous processing for biologic production. Although successes have been shown at small scale, challenges arise when translating continuous processes to large-scale good manufacturing practice (GMP) level. With the help of technological advances and innovative thinking, however, the potential to implement GMP-scale continuous bioprocessing is getting closer to reality. This article looks at real-world experiences of some companies that tested out the implementation of continuous manufacturing systems for GMP-scale biologics manufacture.
Read the article:
Implementing Continuous Bioprocessing: From Theory to Practice
Read the eBook:
Pharmaceutical Technology’s Trends in Manufacturing eBook
Read this article in Pharmaceutical Technology’s May 2022 Trends in Manufacturing eBook.
Feliza Mirasol is the science editor for Pharmaceutical Technology and Pharmaceutical Technology Europe.
Pharmaceutical Technology
eBook: Trends in Manufacturing, May 2022
May 2022
Pages: 36–38
When referring to this article, please cite it as F. Mirasol, “Implementing Continuous Bioprocessing: From Theory to Practice," Pharmaceutical Technology Trends in Manufacturing eBook (May 2022).
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.